COVID-19 exacerbating ESRD induced pericardial effusion requiring pericardial window: A case report

Aryaan Khan; Michael L Hudson; Tyler R Petree

doi:10.1016/j.ijscr.2023.108565

COVID-19 exacerbating ESRD induced pericardial effusion requiring pericardial window: A case report

Int J Surg Case Rep. 2023 Aug:109:108565. doi: 10.1016/j.ijscr.2023.108565. Epub 2023 Jul 26.

Authors

Aryaan Khan¹, Michael L Hudson², Tyler R Petree²

Affiliations

¹ University of Medicine and Health Sciences, Saint Kitts and Nevis. Electronic address: arykhan@umhs-sk.net.
² Department of Surgery, Sinai Grace Hospital, Detroit Medical Center, Detroit, MI, USA.

Abstract

Introduction: Pericardial effusion can lead to cardiac tamponade requiring immediate management. Pericardial windows are an effective measure to surgically drain recurrent effusions.

Presentation of case: We present a case of a 53-year-old male with recurrent pericardial effusion secondary to ESRD and exacerbated by COVID-19 infection, describing the successful management of an uncommon clinical scenario. A sub-xiphoid pericardial window and right sided thoracostomy was performed.

Discussion: There are limited case reports highlighting recurrent pericardial effusion management, secondary to ESRD and COVID-19 in a post renal transplant patient, through a subxiphoid pericardial window.

Conclusion: COVID-19 infection can exacerbate pericardial effusion in a patient with ESRD, post renal transplant. Preventing cardiac tamponade, a sub-xiphoid pericardial window remains an effective measure in treating recurrent pericardial effusion.

Keywords: COVID-19; Cardiac tamponade; ESRD; Pericardial window; Renal transplant.

Publication types

Case Reports